Upcoming events

Supported by

TAVI (Transcatheter aortic valve implantation)

Here you will find all the latest content on transcatheter aortic valve implantations (TAVI) published on this website. Results are listed in chronological order.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Find out more…

Filtered By
TAVI

581 results

How should I treat severe aortic stenosis, severe calcific triple vessel coronary disease and high surgical risk?

11 Jul 2017

A high risk surgical patient with severe bilateral saphenous vein varicosities and previous endovascular repair for infra-renal aortic aneurysm presents with crescendo angina and breathlessness…

EuroIntervention

Growing clinical evidence with the ACURATE neo™ TAVI System

Summary: Join S. Redwood, S. Toggweiler and H. Moellmann as they

Discuss the advantages of the ACURATE neo™ intuitive and predictable implantation procedure with a unique “top-down” deployment Highlight the latest clinical data from the 1-Year follow-up of the SAVI-TF 1000 global registry1

LIVE case: a TAVI procedure with Evolut R

From EUROPCR 2017

Consult this LIVE case on achieving immediate TAVI patient benefit and setting-up for superior long-term outcomes, with LIVE demonstration from Swiss Cardiovascular Centre, Bern University Hospital - Bern, Switzerland.

"Extract from a session sponsored by TNT MEDTRONIC"

Clinical case

A 88-year-old male with a severe aortic stenosis:

Evolut R valve implantedHaemodynamic and angio assessment

Operator

Masahiko Asami

Operator

Stefan Stortecky
Prof. Stefan Windecker

Operator

Stephan Windecker

Wrap-up interview - Insights from REPRISE III, a significant step forward for TAVI

17 May 2017 - From EUROPCR 2017

An increasingly proven re-positionable TAVI device offering a true alternative today? Join M. Götberg, T. Feldman and L. Sondergaard as they discuss emerging results from a recent key international trial underlining the safety, efficacy and non-inferiority of the Lotus valve in a high-risk population. Listen as they tease out the meaning behind these results concerning stroke, paravalvular leak and pacemaker use in high- and lower-risk groups. What are we seeing in the newer-generation Lotus device and what design enhancements are we looking for in the future? How important is experience in implantation techniques? What should we expect from upcoming trials? Watch now...

Omission of predilation in balloon-expandable transcatheter aortic valve implantation: retrospective analysis in a large-volume centre

20 Jun 2017

Salvatore Brugaletta

Reviewer

Salvatore Brugaletta

LIVE case: TAVI in low risk patient

From EUROPCR 2017

Consult this LIVE case on TAVI in low risk patient, which includes a LIVE demonstration from Swiss Cardiovascular Centre, Bern University Hospital - Bern, Switzerland.

Clinical case

A 86-year-old female with severe aortic stenosis:

With balloon dilatationACURATE neoTM valve implantedHaemodynamic and angio assessments

Operator

Masahiko Asami

Operator

Thomas Pilgrim
Prof. Stefan Windecker

Operator

Stephan Windecker

Potential pitfalls of TAVI in low risk patients

21 Jun 2017 - From EUROPCR 2017

Will TAVI be indicated for lower risk patients in 10 years? Join M. Gilard and B. Prendergast as they discuss the implications of enlarging TAVI beginning with the question of whether conventional risk scores used in clinical trials effectively translate into everyday clinical practice. What part will be played by the treatment of bicuspid valves in this lower-risk population? What are the concerns about stroke and the use of protection devices, their evolution and their cost? Or pacemakers? These, and other questions such as the treatment of coronary artery disease in this population are touched on in this fascinating discussion…

LIVE case: multiple valve disease

From EUROPCR 2017

Clinical case

A 80-year-old male with breathlessness:

Previous MVRMitral ViVTAVI with Sapien 3
Dr Bernard Prendergast

Operator

Bernard Prendergast
Dr. Simon Redwood

Operator

Simon Redwood
Jane Hancock

Operator

Jane Hancock

Wrap-up interview - Growing clinical evidence with the ACURATE neo™ TAVI system

18 May 2017 - From EUROPCR 2017

A new transfemoral TAVI device? What makes the self-expanding ACURATE neo™ different from other available valves? Join S. Redwood, S. Toggweiler and H. Moellmann as they spotlight a system that allows for a unique “top-down” deployment along with stable positioning – what is the significance? Are there advantages using this supra-annular valve? What about data from the SAVI-TF 1000 registry, its endpoints and “compelling” results in high-risk patients and pacemaker rates? How does this compare with other valves and how will a new iteration in development today, the Advance Neo, effect regurgitation? Watch now…

LIVE case: CAD in TAVI patient

From EUROPCR 2017

Consult this LIVE case on CAD in TAVI patient, an 87-year-old female patient with CAD and aortic stenosis that include a LIVE demonstration from Saint Thomas' Hospital, London.

Clinical case

A 87-year-old female with CAD and aortic stenosis:

Randomised to ACTIVATION trialSimplified TAVISapien 3 implanted
Dr Bernard Prendergast

Operator

Bernard Prendergast
Dr. Simon Redwood

Operator

Simon Redwood
Jane Hancock

Operator

Jane Hancock